Global Protein in Oncology Market

Oncology is the branch of medical science dealing with cancer research and treatment. There are several research facilities and universities identifying unique proteins in oncology for developing diagnostics. Several studies are underway to discover new proteins that play a role in cancer. Currently there are a number of companies and/or their collaborators engaged in developing several protein drugs in cancer. Surgical treatments and radiation therapy, though effective at treating primary tumors, are not found to be successful in detecting metastatic tumor cells and those flowing in the bloodstream, making treatment of these cancer cells very difficult. Cancer is one of the largest causes of death worldwide and finding leads to cure or control the disease is one of the primary goals of governments globally.

Global Protein in Oncology Market: Segmentation

The global proteins in oncology market has been segmented based on protein type and geography. Protein types include recombinant non-glycosylated proteins, recombinant glycosylated proteins and recombinant peptides. Geographically, North America and Europe lead the global proteins in oncology market thanks to the very stringent regulatory environment for clearing the products. Asia-Pacific countries such as China and India are estimated to be the fastest-growing markets. South Korea and Brazil are also poised to register high growth in the coming years due to boost in biosimilars market. The services that can be provided in the global proteins in oncology market include contract research organizations and contract manufacturing organizations.

Global Protein in Oncology Market: Drivers and Restraints

Worldwide increase in the prevalence of cancer and the rising awareness of the therapeutic and commercial opportunities offered by new oncology treatments have provided a major incentive for the pharmaceutical industry to pursue the development of new agents for the treatment of cancer. Proteins or peptide drugs are usually required to be administered only by injection due to their large and labile nature. Peptide drugs are used effectively in monitoring various tumors and related therapies. They selectively are known to bind responsive versus unresponsive tumors. Therefore, this advantage associated with the use of peptides assists their use in assessing tumor response and evaluating its effectiveness in cancer therapy. The main challenge for the newer generation of recombinant drugs seems to be the new route of administration, new formulations and consequently even higher efficiency and safety. Though the parenteral route of administration is the most common, there are advances being made to deliver medicines through the oral route, which is considered to be the most preferred one due to better patient compliance.

Recently new research has demonstrated that attaching a cancer killer protein to white blood cells annihilates metastasis. Isolation of a protein named as TRAIL by researchers at Cornell University in the U.S. demonstrated killing of cancer cells on contact. The TRAIL protein is binded with leukocytes (white blood cells) that are present across the bloodstream. The cancer cell is essentially known to kill itself when it comes in contact with TRAIL protein. The mechanism has been surprising and unexpectedly effective as compared to targeting the cancer cells with liposomes.

Global Protein in Oncology Market: Competitive Landscape Analysis

The key players contributing to the global proteins in oncology market include Actavis, Inc., Biocon Ltd., Celltrion, Inc., Dr. Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., Hospira, Inc., Merck, Mylan, Inc., Roche Holding Ltd., Sandoz, Teva Pharmaceuticals and Wockhardt Ltd. Expansion of product portfolio enables these companies to gain a competitive advantage over other players in the market. Strengthening of market position by extensive investments in research and development is also one of the business strategies undertaken by the key players. A lot of research is still to be carried out in the protein recombinant drugs in oncology market which will come along with years of efforts and high risk.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Proteins Oncology Market

Pre Book